Research map: Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines

Back to the article

Papers in this map

  1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling · Ash A. Alizadeh · 2000 · 10026 citations · Cited by this paper
  2. Low‐Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T‐Cell Acute Lymphoblastic Leukemia: A Case Series · 2026 · Related
  3. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma · Andreas Rosenwald · 2002 · 3883 citations · Cited by this paper
  4. Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients · 2026 · Related
  5. COSMIC: exploring the world's knowledge of somatic mutations in human cancer · Simon Andrew Forbes · 2014 · 2417 citations · Cited by this paper
  6. Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study · 2026 · Related
  7. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma · Roland P. H. Schmitz · 2018 · 2327 citations · Cited by this paper
  8. Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study · 2026 · Related
  9. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma · Richard Eric Davis · 2010 · 1676 citations · Cited by this paper
  10. Real‐World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States · 2026 · Related
  11. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee · Elı́as Campo · 2022 · 1607 citations · Cited by this paper
  12. Integrative Transcriptomic and Functional Analysis of PKMYT1 Reveals a Potential Therapeutic Target in Chronic Lymphocytic Leukemia · 2026 · Related
  13. Benchmark and integration of resources for the estimation of human transcription factor activities · Luz García‐Alonso · 2019 · 1251 citations · Cited by this paper
  14. Matching‐Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second‐Line Myelofibrosis Therapy · 2026 · Related
  15. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications · George W. Wright · 2020 · 1199 citations · Cited by this paper
  16. Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study · 2026 · Related
  17. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma · Anupama Reddy · 2017 · 1155 citations · Cited by this paper
  18. Sustained Complete Response in Refractory Idiopathic Multicentric Castleman Disease Following a Single CD19 CAR T‐Cell Infusion: A Case Report With Mechanistic Insight · 2026 · Related
  19. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma · George W. Wright · 2003 · 1057 citations · Cited by this paper
  20. Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real‐Life Multicenter Experience. Results From the REDOT_MCL Study · 2026 · Related
  21. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways · Georg Lenz · 2008 · 1007 citations · Cited by this paper
  22. Analysis of the coding genome of diffuse large B-cell lymphoma · Laura Pasqualucci · 2011 · 982 citations · Cited by this paper
  23. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine · Samuel J. Huber · 2012 · 724 citations · Cited by this paper
  24. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report · Stuart Lacy · 2020 · 524 citations · Cited by this paper
  25. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma · Daisuke Ennishi · 2018 · 436 citations · Cited by this paper
  26. Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies · David W. Scott · 2015 · 410 citations · Cited by this paper
  27. Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy · Chulin Sha · 2018 · 317 citations · Cited by this paper
  28. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH · Laura K. Hilton · 2019 · 125 citations · Cited by this paper
  29. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology · Lauren C. Chong · 2018 · 113 citations · Cited by this paper
  30. Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population · Waleed Alduaij · 2022 · 92 citations · Cited by this paper
  31. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs · Rohit Mathur · 2016 · 69 citations · Cited by this paper
  32. Application of the LymphGen classification tool to 928 clinically and genetically‐characterised cases of diffuse large B cell lymphoma (DLBCL) · Hendrik F.P. Runge · 2020 · 63 citations · Cited by this paper
  33. Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics · Zijian Liu · 2018 · 48 citations · Cited by this paper
  34. DLB class : a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma · Bjoern Chapuy · 2024 · 44 citations · Cited by this paper
  35. Repurposing dasatinib for diffuse large B cell lymphoma · Claudio Scuoppo · 2019 · 38 citations · Cited by this paper
  36. Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma · Philip Bucher · 2019 · 33 citations · Cited by this paper
  37. Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas · Hans Günter Drexler · 2016 · 25 citations · Cited by this paper
  38. 2016 WHO Classification update—What's new in lymphoid neoplasms · Eric D. Hsi · 2017 · 25 citations · Cited by this paper
  39. Malignant hematopoietic cell lines: In vitro models for the study of primary mediastinal B-cell lymphomas · Hans Günter Drexler · 2014 · 13 citations · Cited by this paper

Source: OpenAlex (CC0)